Elevated levels of pro-inflammatory oxylipins in older subjects are normalized by flaxseed consumption

Experimental Gerontology

Volumn 59, Issue , 2014, Pages 51-57

  Caligiuri, Stephanie P B ^a,b,c   Aukema, Harold M ^a,c   Ravandi, Amir ^b,d   Pierce, Grant N ^a,b,c  

^a The Inst of Cardiovascular Sciences   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

^c Department of Physiology ^*  (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Aging; Alpha linolenic acid; Eicosanoids; Lipidomics

Indexed keywords

11 HYDROXYDOCOSAHEXAENOIC ACID; 12 HYDROXYEICOSAPENTANOEIC ACID; 13 HYDROXYDOCOSAHEXAENOIC ACID; 16 HYDROXYDOCOSAHEXAENOIC ACID; 18 HYDROXYICOSATETRAENOIC ACID; 20 HYDROXYDOCOSAHEXAENOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; 5 HYDROXYEICOSAPENTAENOIC ACID; 5 HYDROXYICOSATETRAENOIC ACID; 7 HYDROXYDOCOSAHEXAENOIC ACID; 8 HYDROXYICOSATETRAENOIC ACID; 9 HYDROXYEICOSAPENTAENOIC ACID; 9 HYDROXYICOSATETRAENOIC ACID; 9,10,13 TRIHYDROXYOCTADECENOIC ACID; 9,12,13 TRIHYDROXYOCTADECENOIC ACID; HEXANOIC ACID DERIVATIVE; HYDROXYICOSATETRAENOIC ACID; OXYLIPIN; UNCLASSIFIED DRUG; VALERIC ACID DERIVATIVE; AUTACOID;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LINSEED; MALE; MIDDLE AGED; NORMAL HUMAN; SEX DIFFERENCE; AGING; BLOOD; DIET; FLAX; METABOLISM; PLANT SEED; SEXUAL DEVELOPMENT; SINGLE BLIND PROCEDURE; YOUNG ADULT;

ADULT; AGE FACTORS; AGING; DIET; FEMALE; FLAX; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; OXYLIPINS; SEEDS; SEX CHARACTERISTICS; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84912118073     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.04.005     Document Type: Article

References (56)

1. Calder P.C. Omega-3 fatty acids and inflammatory processes. Nutrients 2010, 2:355-374.
2. Oh S.F., Pillai P.S., Recchiuti A., Yang R., Serhan C.N. Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. J. Clin. Invest. 2011, 121:569-581.
3. Serhan C.N., Krishnamoorthy S., Recchiuti A., Chiang N. Novel anti-inflammatory-pro-resolving mediators and their receptors. Curr. Top. Med. Chem. 2011, 11:629-647.
4. Serhan C.N., Petasis N.A. Resolvins and protectins in inflammation resolution. Chem. Rev. 2011, 111:5922-5943.
5. Spite M., Norling L.V., Summers L., Yang R., Cooper D., Petasis N.A., Flower R.J., Perretti M., Serhan C.N. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 2009, 461:1287-1291.
6. Petasis N.A., Akritopoulou-Zanze I., Fokin V.V., Bernasconi G., Keledjian R., Yang R., Uddin J., Nagulapalli K.C., Serhan C.N. Design, synthesis and bioactions of novel stable mimetics of lipoxins and aspirin-triggered lipoxins. Prostaglandins Leukot. Essent Fat. Acids 2005, 73:301-321.
7. Shearer G.C., Newman J.W. Impact of circulating esterified eicosanoids and other oxylipins on endothelial function. Curr. Atheroscler. Rep. 2009, 11:403-410.
8. O'Flaherty J.T., Thomas M.J., Lees C.J., McCall C.E. Neutrophil-aggregating activity of monohydroxyeicosatetraenoic acids. Am. J. Pathol. 1981, 104:55-62.
9. Lundstrom S.L., Yang J., Kallberg H.J., Thunberg S., Gafvelin G., Haeggstrom J.Z., Gronneberg R., Grunewald J., van Hage M., Hammock B.D., Eklund A., Wheelock A.M., Wheelock C.E. Allergic asthmatics show divergent lipid mediator profiles from healthy controls both at baseline and following birch pollen provocation. PLoS One 2012, 7:e33780.
10. Wakefield A.P., Ogborn M.R., Ibrahim N., Aukema H.M. A dietary conjugated linoleic acid treatment that slows renal disease progression alters renal cyclooxygenase-2-derived prostanoids in the Han: SPRD-cy rat. J. Nutr. Biochem. 2012, 23(8):908-914.
11. Sankaran D., Bankovic-Calic N., Ogborn M.R., Crow G., Aukema H.M. Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease. Am. J. Physiol. Ren. Physiol. 2007, 293:F821-F830.
12. Ogletree M.L. Overview of physiological and pathophysiological effects of thromboxane A2. Fed. Proc. 1987, 46:133-138.
13. Kulkarni P.S., Roberts R., Needleman P. Paradoxical endogenous synthesis of a coronary dilating substance from arachidonate. Prostaglandins 1976, 12:337-353.
14. Serhan C.N., Petasis N.A. Resolvins and protectins in inflammation resolution. Chem. Rev. 2011, 111:5922-5943.
15. Zhao X., Yamamoto T., Newman J.W., Kim I.H., Watanabe T., Hammock B.D., Stewart J., Pollock J.S., Pollock D.M., Imig J.D. Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage. J. Am. Soc. Nephrol. 2004, 15:1244-1253.
16. Warford-Woolgar L., Peng C.Y., Shuhyta J., Wakefield A., Sankaran D., Ogborn M., Aukema H.M. Selectivity of cyclooxygenase isoform activity and prostanoid production in normal and diseased Han:SPRD-cy rat kidneys. Am. J. Physiol. Ren. Physiol. 2006, 290:F897-F904.
17. Ogborn M.R., Nitschmann E., Bankovic-Calic N., Weiler H.A., Fitzpatrick-Wong S., Aukema H.M. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease. Kidney Int. 2003, 64:1214-1221.
18. Oltman C.L., Weintraub N.L., VanRollins M., Dellsperger K.C. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ. Res. 1998, 83:932-939.
19. Fischer D.B., Christman J.W., Badr K.F. Fifteen-S-hydroxyeicosatetraenoic acid (15-S-HETE) specifically antagonizes the chemotactic action and glomerular synthesis of leukotriene B4 in the rat. Kidney Int. 1992, 41:1155-1160.
20. Lonnqvist F., Nyberg B., Wahrenberg H., Arner P. Catecholamine-induced lipolysis in adipose tissue of the elderly. J. Clin. Invest. 1990, 85:1614-1621.
21. Petersen K.F., Befroy D., Dufour S., Dziura J., Ariyan C., Rothman D.L., DiPietro L., Cline G.W., Shulman G.I. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003, 300:1140-1142.
22. Carver J.D., Benford V.J., Han B., Cantor A.B. The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res. Bull. 2001, 56:79-85.
23. Keenan A.H., Pedersen T.L., Fillaus K., Larson M.K., Shearer G.C., Newman J.W. Basal omega-3 fatty acid status affects fatty acid and oxylipin responses to high-dose n3-HUFA in healthy volunteers. J. Lipid Res. 2012, 53(8):1662-1669.
24. Shearer G.C., Harris W.S., Pedersen T.L., Newman J.W. Detection of omega-3 oxylipins in human plasma and response to treatment with omega-3 acid ethyl esters. J. Lipid Res. 2010, 51:2074-2081.
25. Caligiuri S.P., Love K., Winter T., Gauthier J., Taylor C.G., Blydt-Hansen T., Zahradka P., Aukema H.M. Dietary linoleic acid and alpha-linolenic acid differentially affect renal oxylipins and phospholipid fatty acids in diet-induced obese rats. J. Nutr. 2013, 143:1421-1431.
26. Aliani M., Ryland D., Pierce G.N. Effect of flax addition on the flavor profile and acceptability of bagels. J. Food Sci. 2012, 77:S62-S70.
27. Aliani M., Ryland D., Pierce G.N. Effect of flax addition on the flavor profile of muffins and snack bars. Food Res. Int. 2011, 44:2489.
28. Bassett C.M., Rodriguez-Leyva D., Pierce G.N. Experimental and clinical research findings on the cardiovascular benefits of consuming flaxseed. Appl. Physiol. Nutr. Metab. 2009, 34:965-974.
29. Austria J.A., Richard M.N., Chahine M.N., Edel A.L., Malcolmson L.J., Dupasquier C.M., Pierce G.N. Bioavailability of alpha-linolenic acid in subjects after ingestion of three different forms of flaxseed. J. Am. Coll. Nutr. 2008, 27:214-221.
30. Ander B.P., Edel A.L., McCullough R., Rodriguez-Leyva D., Rampersad P., Gilchrist J.S., Lukas A., Pierce G.N. Distribution of omega-3 fatty acids in tissues of rabbits fed a flaxseed-supplemented diet. Metabolism 2010, 59:620-627.
31. Edel A.L., Aliani M., Pierce G.N. Supported liquid extraction in the quantitation of plasma enterolignans using isotope dilution GC/MS with application to flaxseed consumption in healthy adults. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2013, 912:24-32.
32. Dupasquier C.M., Dibrov E., Kneesh A.L., Cheung P.K., Lee K.G., Alexander H.K., Yeganeh B.K., Moghadasian M.H., Pierce G.N. Dietary flaxseed inhibits atherosclerosis in the LDL receptor-deficient mouse in part through antiproliferative and anti-inflammatory actions. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H2394-H2402.
33. Francis A.A., Deniset J.F., Austria JA M., Lavallee R.K., Maddaford G.G., Hedley T.E., Dibrov E., Pierce G.N. The effects of dietary flaxseed on atherosclerotic plaque regression. Am. J. Physiol. Heart Circ. Physiol. 2013, 304(12):H1743-H1751.
34. Tomaz Pacheco J., Beltrame Daleprame J., Teles Boaventura G. Impact of dietary flaxseed (Linum usitatissimum) supplementation on biochemical profile in healthy rats. Nutr. Hosp. 2011, 26:798-802.
35. Bassett C.M., McCullough R.S., Edel A.L., Patenaude A., LaVallee R.K., Pierce G.N. The alpha-linolenic acid content of flaxseed can prevent the atherogenic effects of dietary trans fat. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H2220-H2226.
36. Rodriguez-Leyva D., Weighell W., Edel A.L., Lavallee R., Dibrov E., Pinneker R., Maddaford T.G., Ramjiawan B., Aliani M., Guzman R., Pierce G.N. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension 2013, 62(6):1081-1089.
37. Patenaude A., Rodriguez-Leyva D., Edel A.L., Dibrov E., Dupasquier C.M., Austria J.A., Richard M.N., Chahine M.N., Malcolmson L.J., Pierce G.N. Bioavailability of alpha-linolenic acid from flaxseed diets as a function of the age of the subject. Eur. J. Clin. Nutr. 2009, 63:1123-1129.
38. Matthan N.R., Ip B., Resteghini N., Ausman L.M., Lichtenstein A.H. Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions. J. Lipid Res. 2010, 51:2826-2832.
39. Deems R., Buczynski M.W., Bowers-Gentry R., Harkewicz R., Dennis E.A. Detection and quantitation of eicosanoids via high performance liquid chromatography-electrospray ionization-mass spectrometry. Methods Enzymol. 2007, 432:59-82.
40. Hall L.M., Murphy R.C. Electrospray mass spectrometric analysis of 5-hydroperoxy and 5-hydroxyeicosatetraenoic acids generated by lipid peroxidation of red blood cell ghost phospholipids. J. Am. Soc. Mass Spectrom. 1998, 9:527-532.
41. Goetzl E.J., Brash A.R., Tauber A.I., Oates J.A., Hubbard W.C. Modulation of human neutrophil function by monohydroxy-eicosatetraenoic acids. Immunology 1980, 39:491-501.
42. Chavis C., Fraissinet L., Chanez P., Thomas E., Bousquet J. A method for the measurement of plasma hydroxyeicosatetraenoic acid levels. Anal. Biochem. 1999, 271:105-108.
43. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured?. Nutr. Rev. 2007, 65:S173-S176.
44. Statistics Canada Health Facts Sheet - Canadian Community Health Survey http://www.statcan.gc.ca.proxy2.lib.umanitoba.ca/pub/82-625-x/82-625-x2013001-eng.htm.
45. De Martinis M., Franceschi C., Monti D., Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp. Mol. Pathol. 2006, 80:219-227.
46. Vasan R.S., Sullivan L.M., Roubenoff R., Dinarello C.A., Harris T., Benjamin E.J., Sawyer D.B., Levy D., Wilson P.W., D'Agostino R.B., Framingham Heart Study Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 2003, 107:1486-1491.
47. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580.
48. Totani Y., Saito Y., Ishizaki T., Sasaki F., Ameshima S., Miyamori I. Leukotoxin and its diol induce neutrophil chemotaxis through signal transduction different from that of fMLP. Eur. Respir. J. 2000, 15:75-79.
49. Moran J.H., Weise R., Schnellmann R.G., Freeman J.P., Grant D.F. Cytotoxicity of linoleic acid diols to renal proximal tubular cells. Toxicol. Appl. Pharmacol. 1997, 146:53-59.
50. Kinniry P., Amrani Y., Vachani A., Solomides C.C., Arguiri E., Workman A., Carter J., Christofidou-Solomidou M. Dietary flaxseed supplementation ameliorates inflammation and oxidative tissue damage in experimental models of acute lung injury in mice. J. Nutr. 2006, 136:1545-1551.
51. Hallund J., Tetens I., Bugel S., Tholstrup T., Bruun J.M. The effect of a lignan complex isolated from flaxseed on inflammation markers in healthy postmenopausal women. Nutr. Metab. Cardiovasc. Dis. 2008, 18:497-502.
52. Faintuch J., Horie L.M., Barbeiro H.V., Barbeiro D.F., Soriano F.G., Ishida R.K., Cecconello I. Systemic inflammation in morbidly obese subjects: response to oral supplementation with alpha-linolenic acid. Obes. Surg. 2007, 17:341-347.
53. Gillingham L.G., Harding S.V., Rideout T.C., Yurkova N., Cunnane S.C., Eck P.K., Jones P.J. Dietary oils and FADS1-FADS2 genetic variants modulate [13C]alpha-linolenic acid metabolism and plasma fatty acid composition. Am. J. Clin. Nutr. 2013, 97:195-207.
54. Giltay E.J., Gooren L.J., Toorians A.W., Katan M.B., Zock P.L. Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects. Am. J. Clin. Nutr. 2004, 80:1167-1174.
55. Romanski S.A., Nelson R.M., Jensen M.D. Meal fatty acid uptake in adipose tissue: gender effects in nonobese humans. Am. J. Physiol. Endocrinol. Metab. 2000, 279:E455-E462.
56. Jensen M.D. Gender differences in regional fatty acid metabolism before and after meal ingestion. J. Clin. Invest. 1995, 96:2297-2303.